Business Standard

Monday, December 23, 2024 | 07:57 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Blood thinners may boost survival rates of coronavirus patients: Study

The Washington Post reported that the results of the analysis, conducted over 2,733 patients, were published on Wednesday in the Journal of the American College of Cardiology

hospital, beds, patients, doctors, nurses, health care, health workers, coronavirus, testing, vaccine
Premium

In late April, scientists also reported that an arthritis drug made by Regeneron and Sanofi that had drawn enthusiasm from investors early on produced disappointing results in clinical trials, according to The Washington Post.

ANI New Delhi
Treating coronavirus patients with blood thinners may help in boosting their prospects for survival, according to preliminary findings from physicians at New York City's largest hospital system that offers another source of hope in treating the deadly infection.
The Washington Post reported that the results of the analysis, conducted over 2,733 patients, were published on Wednesday in the Journal of the American College of Cardiology.
In an interview to the newspaper, Valentin Fuster, a physician in chief at Mount Sinai Hospital and one of the study's authors, said that the observations were based only on a review of medical records and that

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in